Dunhill Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$660 Buy
110
+105
+2,100% +$10.1K ﹤0.01% 1145
2026
Q2
$468 Hold
5
– – ﹤0.01% 1146
2026
Q1
$386 Buy
5
+2
+67% +$141 ﹤0.01% 1145
2025
Q4
$201 Buy
+3
New +$202 ﹤0.01% 1118

Other funds holding HALO

Dunhill Financial's HALO Position: Q3 2026 in Review

Dunhill Financial increased its Halozyme (HALO) stake by 2,100% in Q3 2026, buying an estimated $10.1K and bringing the position to 110 shares worth $660. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Dunhill Financial first reported a position in HALO in Q4 2025 and has held it in 4 quarters since. 774 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Dunhill Financial held 110 shares of Halozyme worth $660 as of Q3 2026.
  • Dunhill Financial bought 105 Halozyme shares in Q3 2026, an estimated $10.1K.
  • Halozyme made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1145 holding.
  • Dunhill Financial first reported a position in Halozyme in Q4 2025 and has held it in 4 quarters since.
  • 774 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.